Management of intraductal papillary mucinous neoplasms

Current Gastroenterology Reports

Volumn 10, Issue 2, 2008, Pages 136-143

  Crippa, Stefano ^a   Castillo, Carlos Fernández del ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CARCINOEMBRYONIC ANTIGEN; DNA; FASCIN; FLUORODEOXYGLUCOSE F 18; K RAS PROTEIN; MUCIN; MUCIN 2; PROTEIN P16; PROTEIN P53; SECRETIN; SMAD4 PROTEIN; SONIC HEDGEHOG PROTEIN;

ASPIRATION BIOPSY; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DNA DAMAGE; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MOLECULAR BIOLOGY; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATHOGENESIS; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; RECURRENCE RISK; REVIEW; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT INDICATION; CANCER STAGING; COLLOID CARCINOMA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MORTALITY; NEEDLE BIOPSY; PANCREAS TUMOR; PROGNOSIS; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA, MUCINOUS; BIOPSY, NEEDLE; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; ENDOSONOGRAPHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 47149104700     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0034-7     Document Type: Review

References (45)

1. Ohashi K, Murakami Y, Murayama M, et al.: Four cases of mucus secreting pancreatic cancer. Prog Dig Endoscopy 1982, 20:348-351.
2. Tanaka M, Chari S, Adsay V, et al.: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006, 6:17-32.
3. Longnecker DS, Adler G, Hruban HR, et al.: Intraductal papillary mucinous neoplasms of the pancreas. In Pathology and Genetics of Tumors of the Digestive System. Edited by Hamilton SR, Aaltonen LA. London: IARC Press, 1999:237-240.
4. Sohn TA, Yeo CJ, Cameron JL, et al.: Intraductal papillary mucinous neoplasms of the pancreas: An updated experience. Ann Surg 2004, 239:788-797.
5. Salvia R, Fernández-del Castillo C, Bassi C, et al.: Mainduct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004, 239:678-685.
6. Chari ST, Yadav D, Smyrk TC, et al.: Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002, 123:1500-1507.
7. Kobari M, Egawa S, Shibuya K, et al.: Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg 1999, 134:1131-1136.
8. Sugiyama M, Izumisato Y, Abe N, et al.: Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003, 90:1244-1249.
9. Schmidt CM, White PB, Waters JA, et al.: Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg 2007, 246:644-654.
10. Terris B, Ponsot P, Paye F, et al.: Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000, 24:1372-1377.
11. Rodriguez JR, Salvia R, Crippa S, et al.: Branch-duct intraductal papillary mucinous neoplasms: Observations in 145 patients who underwent resection. Gastroenterology 2007, 133:72-79.
12. Pelaez-Luna M, Chari ST, Smyrk TC, et al.: Do consensus indications for resection in branch-duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007, 102:1759-1764.
13. Levy P, Jouannaud V, O'Toole D, et al.: Natural history of intraductal papillary mucinous tumors of the pancreas: Actuarial risk of malignancy. Clin Gastroenterol Hepatol 2006, 4:460-468.
14. Furukawa T, Kloppel G, Adsay NV, et al.: Classification of types of intraductal papillary mucinous neoplasms of the pancreas: A consensus study. Virchows Arch 2005, 447:794-799.
15. Ban S, Naitoh Y, Mino-Kenudson M, et al.: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathologic difference between 2 major types. Am J Surg Pathol 2006, 30:1561-1569.
16. Schonleben F, Qiu W, Bruckman KC, et al.: BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas. Cancer Lett 2007, 249:242-248.
17. Miyasaka Y, Nagai E, Yamaguchi H, et al.: The role of DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2007, 13:4371-4377.
18. Yamaguchi H, Inoue T, Eguchi T, et al.: Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007, 20:552-561.
19. Liu MS, Yang PY, Yeh TS: Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas 2007, 34:340-346.
20. Ohuchida K, Mizumoto K, Fujita, et al.: Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice. J Pathol 2006, 210:42-48.
21. Carbognin G, Vamboni G, Pinali L, et al.: Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging 2006, 31:320-325.
22. Pilleul F, Rochette A, Partensky C, et al.: Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging 2005, 21:237-244.
23. Sahani DV, Kadavigere R, Blake M, et al.: Intraductal papillary mucinous neoplasm of pancreas: Multi-detector row CT with 2D curved reformations - correlation with MRCP. Radiology 2006, 238:560-569.
24. Song SJ, Lee JM, Kim YJ, et al.: Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 2007, 26:86-93.
25. WatersOJA, Schmidt CM, Pinchot JW, et al.: CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2007, [Epub ahead of print].
26. Stelow EB, Stanley MW, Bardales RH, et al.: Intraductal papillary-mucinous neoplasm of the pancreas. The findings and limitations of cytologic samples obtained by endoscopic ultrasound-guided fine-needle aspiration. Am J Clin Pathol 2003, 120:398-404.
27. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al.: Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study. Gastroenterology 2004, 126:1330-1336.
28. Michaels PJ, Brachtel EF, Bounds BC, et al.: Intraductal papillary mucinous neoplasm of the pancreas: Cytologic features predict histologic grade. Cancer 2006, 108:163-173.
29. Sperti C, Pasquali C, Decet G, et al.: F-18-fluorodeoxy-glucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study. J Gastrointest Surg 2005, 9:22-28.
30. Jang JY, Kim SW, Ahn YJ, et al.: Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: Is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005, 12:124-132.
31. Bassi C, Butturini G, Salvia R, et al.: Open pancreaticogastrostomy after pancreaticoduodenectomy: A pilot study. J Gastrointest Surg 2006, 10:1072-1080.
32. Gigot JF, Deprez P, Sempoux C, et al.: Surgical management of intraductal papillary mucinous tumors of the pancreas: The role of routine frozen section of the surgical margin, intraoperative endoscopic staged biopsies of the Wirsung duct, and pancreaticogastric anastomosis. Arch Surg 2001, 136:1256-1262.
33. Crippa S, Bassi C, Warshaw AL, et al.: Middle pancreatectomy: indications, operative and long-term results. Ann Surg 2007, 246:69-76.
34. Couvelard A, Sauvanet A, Kianmanesh R, et al.: Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable. A prospective evaluation. Ann Surg 2005, 242:774-780.
35. Falconi M, Salvia R, Bassi C, et al.: Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 2001, 88:376-381.
36. White R, D'Angelica M, Katabi N, et al.: Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 2007, 204: 987-995.
37. Salvia R, Crippa S, Falconi M, et al.: Branch-duct intraductal papillary mucinous neoplasms of the pancreas: To operate or not to operate? Gut 2007, 56:1086-1090.
38. D'Angelica M, Brennan MF, Suriawinata AA, et al.: Intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2004, 239:400-408.
39. Choi MG, Kim SW, Han SS, et al.: High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg 2006, 141:51-56.
40. Eguchi H, Ishikawa O, Ohigashi H, et al.: Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery 2006, 139:749-754.
41. Riall TS, Stager VM, Nealon WH, et al.: Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinoma. J Am Coll Surg 2007, 204:803-814.
42. Doi R, Fujimoto K, Wada M, Imamura M: Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 2002, 132:80-85.
43. Matsumoto T, Aramaki M, Yada K, et al.: Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2003, 36:261-265.
44. Choi BS, Kim TK, Kim AY, et al.: Differential diagnosis of benign and malignant intraductal papillary mucious tumors of the pancreas: MR cholangio-pancreatography and MR angiography. Korean J Radiol 2003, 4:157-162.
45. Kitagawa Y, Unger TA, Taylor S, et al.: Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003, 7:12-19.